DV
Dividend Vision

BMGL Stock — Basel Medical Group Ltd Ordinary Shares

Basel Medical Group Ltd Ordinary Shares (BMGL)

Updated October 16, 2026.

BMGL is a Stock. Total return is -92.6% over the past 1.6 years, 123.6 points behind SPY at 31.0%.

Basel Medical Group Ltd is a healthcare services company headquartered in Singapore that provides orthopedic care (including joint replacements, sports medicine, and spine surgery), neurosurgical treatments, and general medical services including health screening, mental health, and women's health. The company's distribution profile is not currently established. This operating company may appeal to investors seeking equity exposure to healthcare services in Southeast Asia.

BMGL performance versus SPY

Price and return data through 2026-10-16.

Total return is -92.6% over the past 1.6 years, 123.6 points behind SPY at 31.0%. Over the past year its total return — price change plus distributions reinvested — is -78.5%. Its deepest 1-year drawdown was 84.8%.

WindowTotal returnCAGR
1M-3.7%—
3M-29.5%—
6M-45.1%—
YTD-32.8%—
1Y-78.5%—
Since inception (1.6 years)-92.6%-79.60%

BMGL key facts

Asset type
Stock
Asset class
Equity
Inception date
02/25/2025
Distribution frequency
None
Last close
$3.95 (as of 2026-10-16)
Market cap
$6,249,338
Average volume
1448506.0
Payout ratio
0.0%
EPS
$-4.81

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BMGL risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 84.8%.

Who may consider BMGL — and who may not

It is a weaker fit for investors who need monthly cash flow (BMGL does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BMGL

Tagged: Healthcare.

Frequently asked questions

Does BMGL pay monthly?

No. BMGL does not currently distribute.

When does BMGL pay a dividend?

BMGL does not currently distribute.

How has BMGL performed?

Total return is -92.6% over the past 1.6 years, 123.6 points behind SPY at 31.0%. Over the past year its total return — price change plus distributions reinvested — is -78.5%. Its deepest 1-year drawdown was 84.8%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.